A new viral-based vector that can be inhaled into the lungs could boost the anti-cancer response of the body in patients diagnosed…
Oncotelic Therapeutics maintained the fair value of its 45% GMP Biotechnology JV stake at approximately $388 million in Q1 2026…
BioMedWire Editorial Coverage: As oncology drug-development costs continue climbing and regulatory pathways become increasingly complex, biotechnology companies are placing renewed emphasis…
The Centers for Disease Control and Prevention (CDC) in the U.S. has extended the recently issued travel ban on individuals…
According to advice published in the Netherlands last week, climate change is increasing the risk of not just infectious diseases but also…
Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma is advancing a clinical-stage…
Earth Science Tech has positioned itself as a diversified healthcare holding company focused on pharmaceutical compounding, telemedicine, healthcare services, and…
GelrinC(R) is positioned as a potential first-in-class, off-the-shelf solution for knee cartilage repair in the U.S., offering a single-step procedure…
OTLC completed a $12.5M monetization of its N2B CNS delivery system with Lunai Bioworks, targeting Alzheimer’s and biodefense applications The…
Researchers at the University of Virginia have conducted a study that offers new insights into what happens when there are errors in…